Skip to main content
HLIO $81.49 +0.43%
HLIO logo

HLIO · Helios Technologies, Inc.

Track HLIO — free
$81.49 +0.35 (+0.43%) At close · Aug 14
Market Cap
$2.69B
Shares
32.95M
All earnings calls

Earnings call · FY2025 Q4

Helios Technologies, Inc. Q4 FY2025 Earnings Call

Helios Technologies, Inc. Q4 FY2025 Earnings Call

Concluded Mar 3, 2026 Audio replay
Mar 3, 2026 52:57 35 turns
Period
FY2025 Q4
Runtime
52:57
Sources
4 artifacts

Executive readout · one minute

What matters this quarter

Helios Technologies reported Q4 2025 net sales of $211 million, up 17% year-over-year (29% pro forma), with full-year sales up 4% to $839 million and record $127 million in cash from operations for FY25, alongside expanded gross margins and reduced leverage.

Margin Expansion and Operational Excellence 12 Capital Return and Investor Day 11 Portfolio Optimization (CFP Divestiture) 10 New Product Launches and Innovation 7 2025 Turnaround and Growth Recovery 5 Hydraulics Segment End-Market Conditions 5

Management tone

Confident

Net tone +55 · low hedging

Grounding quotes
  • “Results finished ahead of recent expectations, with all businesses reporting quarterly sales and earnings growth, leading to full year sales growth for the first time in three years, while also delivering record free cash flow.”
  • “Fourth quarter sales exceeded our expectations, up 17% to $211 million, resulting in 4% growth for the full year to $839 million.”
  • “Sales and orders accelerated in the second half of the year, reflecting the increasing impact of our go-to-market initiatives and our industry-leading innovative products.”
  • “Throughout 2025, we overcame numerous challenges.”

Forward guidance

6 guided metrics

Management's latest ranges and targets are included below.

Research coverage

4 live sources

Switch sources without leaving this page or losing your listening position.

Revenue · derived Q4 $210.70M +17.4% YoY
Gross margin · derived Q4 33.6% +3.5 pp YoY
Net income · derived Q4 $19.40M +304.2% YoY

Research materials

Open the source you need; every reader stays inside this workspace.

Key takeaways

What improved, and what deserves a closer read.

Constructive signals

  • Q4 net sales grew 17% to $211M; full-year sales grew 4% to $839M, the first full year of growth in three years
  • Q4 gross margin expanded 350 bps to 33.6% on volume, mix, and productivity gains; full-year gross margin up 100 bps to 32.3%
  • Q4 adjusted diluted EPS of $0.81, up 145% year-over-year; full-year adjusted diluted EPS of $2.56, up 22%
  • Generated a record $46M in Q4 cash from operations and a record $127M for FY25
  • Reduced net-debt-to-adjusted EBITDA leverage to 1.8x from 2.6x, with $82M (18%) total debt reduction; liquidity surpassed total debt
  • Initiated 2026 outlook of +4% to +9% full-year sales growth over 2025 pro forma

Risks & pressure points

  • Q4 ended January 3, 2026 amid macroeconomic headwinds including PMI and Industrial Production contraction, global tariffs, geopolitical uncertainty, and a weak consumer market
  • Health and wellness business remains pressured as the U.S. spa market is still soft
  • Marine market early boat season sentiment is mixed with retail still down, with no significant growth expected
  • Returned to year-over-year profitable sales growth only in the back half of the year after a 'slow and uneven' 2025
  • EBITDA margin of 20.1% in Q4 remains well below the mid-twenties target that management indicated could take time to achieve

Key moments

Jump directly to management's words in the synchronized transcript.

“Sales and orders accelerated in the second half of the year, reflecting the increasing impact of our go-to-market initiatives and our industry-leading innovative products. In conjunction with the CONEXPO trade show this week, we are excited to begin the rollout of our next wave of products, and our plans for 2026 will be to continue that at an elevated pace.” Sean Bagan, CEO
“We introduced a new share repurchase program in 2025 and repurchased 1% of the company’s outstanding shares throughout the year. This share buyback model as a form of shareholder return marks the first for the company. Importantly, we continued our longstanding practice of paying cash dividends, which we have done for 116 consecutive quarters, or over 28 years.” Sean Bagan, CEO

Forward guidance

From the 8-K filed Mar 2, 2026.

Metric Guided
Sales table
FY26 Outlook
$820M – $860M
Adjusted EBITDA margin table
FY26 Outlook
19.5% – 21%
Adjusted Diluted EPS table
FY26 Outlook
$2.60 – $2.90
Adjusted EBITDA margin table
1Q26 Outlook
19.5% – 20.5%
Sales
1Q26 Outlook
$218M – $223M
Adjusted Diluted EPS table
1Q26 Outlook
$0.65 – $0.70

Quarter detail

How the reported period landed and where the business moved.

Capital returned

Dividend / share
$0.12
Full-screen source Call document